Roger Dansey - 20 Dec 2021 Form 4 Insider Report for Seagen Inc. (SGEN)

Role
Chief Medical Officer
Signature
By: /s/ Jennifer Prosba For: Roger D. Dansey
Issuer symbol
SGEN
Transactions as of
20 Dec 2021
Transactions value $
-$85,520
Form type
4
Date filed
22 Dec 2021, 16:33
Previous filing
27 Sep 2021
Next filing
05 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGEN Common Stock Sale -$42K -280 -0.31% $149.85 88.6K 20 Dec 2021 Direct F1, F2
transaction SGEN Common Stock Sale -$43.6K -280 -0.32% $155.58 88.4K 21 Dec 2021 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
F3 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.